This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • The ImPact of Trimetazidine on MicrOcirculation Af...
Clinical trial

The ImPact of Trimetazidine on MicrOcirculation After Stenting for Stable Coronary Artery Disease (PATMOS)

Read time: 1 mins
Last updated:29th Mar 2014

The study should enrol 50 patients with stable coronary artery disease scheduled for elective percutaneous coronary intervention of single, de novo lesion of native coronary artery. Patients will be randomized to orally given trimetazidine on top of standard medical therapy for stable coronary artery disease versus standard therapy only. The randomization will begin 48 hrs before intervention. Index of microcirculatory resistance (IMR) will be measured by thermodilution method using coronary pressure and temperature wire before and after stent implantation. Echocardiography will be performed before intervention and within 30 minutes after intervention. Patients will be followed clinically for a period of one year.

Category Value
Study start date 2014-03-29

View full details